Colilen IBS- Irritable Bowel Syndrome- adults-Phase III |
28/11/2018 |
ABOCA |
Anti SARS-CoV-2 gammaglobulin |
30/06/2021 |
AICA |
Biomodulina T in pediatric septic shock. Exploratory study |
03/08/2020 |
BIOCEN |
Efficacy of nasal provocation test with VALERGEN-DP, DS and BT |
15/04/2019 |
BIOCEN |
VALERGEN-combination of routes- Asthma-Adults-Phase II |
14/02/2019 |
BIOCEN |
Cicatrix Cream in cutaneous striae |
2009-10-23 |
CATALYSIS |
Cicatrix Cream in post surgical scarps and epidermic burn |
2009-10-23 |
CATALYSIS |
Efficacy of the Glicigen – Viusid in the treatment of external genitals anus wart in children |
2010-09-04 |
CATALYSIS |
Kardioli® nutritional supplement versus placebo in patients with chronic heart failure. Phase II. |
03/03/2023 |
CATALYSIS |
Obex® - Overweight and Obese - Adults - Phase III |
17/04/2018 |
CATALYSIS |
Oncoxin-Viusid-Advanced or metastatic ovarian epithelial cancer-Adult women-Phase II |
17/04/2018 |
CATALYSIS |
Glizigen® and Oncoxin®-Viusid® in cervical intraepithelial lesions of adult women. Phase II |
09/05/2018 |
CATALYSIS |
Oncoxin-Viusid/Stomach and gastric esophagus union cancer / Adults / Phase II |
10/05/2018 |
CATALYSIS |
Oncoxin®-Viusid®- Quality of life of patients with metastatic colorectal adenocarcinoma-adults-Phase II |
05/06/2018 |
CATALYSIS |
Oncoxin-Viusid / Pancreatic adenocarcinoma / Adults / Phase II |
01/08/2018 |
CATALYSIS |
Effect and safety of the use of Viusid® on the quality of life of patients with Chronic Kidney Disease on Hemodialysis. |
27/03/2023 |
CATALYSIS |
Quality of life and safety of CARMINAL® nutritional supplement in patients with mild or moderate ulcerative colitis |
29/02/2024 |
CATALYSIS |
Quality of Life and safety of the nutritional supplement Deprexil® or Placebo in combination with cognitive stimulation treatment in patients with Mild Cognitive Impairment and Mild Alzheimer's Dementia. |
07/03/2024 |
CATALYSIS |
Phase III clinical trial: Dermofural®. Mild infection in diabetic foot ulcer |
24/04/2023 |
CBQ |
Melagenina Plus - Vitiligo – phase IV |
14/01/2019 |
CHP |